Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

Encouraging interim results have supported Roche’s decision to move trontinemab into a pivotal Phase III programme.

Weight loss drugs such as semaglutide, found in Ozempic and Wegovy, are tied to a 40% reduced risk of an Alzheimer's disease ...